Andrea brings more than 20 years’ experience in the biopharmaceutical industry to Atea’s management team.
Prior to joining Atea, Andrea served as Senior Vice President, Strategy and Finance at iBio from 2011 to 2012, General Counsel and Secretary of Tolerx from 2007 to 2011 and Executive Vice President of Idenix Pharmaceuticals from 1998 to 2007.
Earlier in her career, Andrea worked with the law firms Kelley Drye & Warren LLP and Edwards & Angell LLP (now Locke Lorde), and in the assurance practice of PricewaterhouseCoopers as a certified public accountant.
Andrea holds a BS in Accounting from Providence College and a JD from Boston College Law School.
Back to Full Team
Atea is a clinical-stage biopharmaceutical company committed to addressing unmet medical needs through novel antiviral treatments.
Copyright © 2023 By Atea Pharmaceuticals. All Rights Reserved. Privacy Policy | Terms of Use